Takeda and HemoShear partner to discover new treatments for liver diseases
Japan ’s Takeda Pharmaceutical Company has collaborated with US-based biotechnology company HemoShear Therapeutics to discover and develop new therapeutics for liver diseases, including non-alcoholic steatohepatitis (NASH).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Alcoholism | Biotechnology | Japan Health | Liver | Liver Disease | Pharmaceuticals | Urology & Nephrology